STOCK TITAN

Francis Lo reports multiple 10b5-1 share sales for ADPT (NASDAQ: ADPT)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ADPT insider filing: proposed resale of Common Stock by Francis Lo under Rule 144 and 10b5-1 plan. The filing lists multiple recent sales by Francis Lo, including 38,074 shares on 03/05/2026 for $574,536.66 and earlier 10b5-1 sales of 79,590 shares on 01/12/2026 for $1,411,393.35. The record also lists 30,593 Restricted Stock Units dated 03/04/2025.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice showing multiple 10b5-1 dispositions by Francis Lo.

The excerpt documents scheduled dispositions under a 10b5-1 plan with discrete sale dates and dollar proceeds: $574,536.66 on 03/05/2026 and $1,411,393.35 on 01/12/2026.

These entries are procedural notices of resale activity and include a separate line for 30,593 Restricted Stock Units dated 03/04/2025. Timing and cash‑flow mechanics beyond the listed proceeds are not detailed in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What sales does the ADPT Form 144 list for Francis Lo?

It lists multiple sales including 38,074 shares on 03/05/2026 for $574,536.66. It also shows 79,590 shares on 01/12/2026 for $1,411,393.35 and other dated 10b5-1 sales.

Does the filing indicate these were executed under a 10b5-1 plan for ADPT?

Yes. The entries are labeled as 10b5-1 Sales for Francis Lo, indicating the reported dispositions used a pre-arranged trading plan as stated in the excerpt.

Are any restricted securities mentioned in the ADPT excerpt?

The excerpt shows 30,593 Restricted Stock Units dated 03/04/2025. The line identifies these RSUs but does not state whether they were sold or withheld in these transactions.

What proceeds are reported for the largest listed sale in the excerpt?

The largest proceeds shown are $1,773,381.19 corresponding to 113,890 shares on 12/15/2025 as listed in the excerpt. Each sale row pairs share count with dollar proceeds.
Adaptive Biotechnologies

NASDAQ:ADPT

View ADPT Stock Overview

ADPT Rankings

ADPT Latest News

ADPT Latest SEC Filings

ADPT Stock Data

2.19B
150.68M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SEATTLE